Discovery and structure–activity relationships of a novel oxazolidinone class of bacterial type II topoisomerase inhibitors

Amanda Lyons, James D. Kirkham, Kevin Blades, David Orr, Elizabeth M. Dauncey, Oliver H. Smith, Emma Dick, Rolf Walker, Teresa Matthews, Adam Bunt, Jonathan Finlayson, Ian M. Morrison, Victoria J. Savage, Emmanuel Moyo, Hayley S. Butler, Rebecca Newman, Nicola Ooi, Andrew Smith, Cédric Charrier, Andrew J. Ratcliffe, Neil R. Stokes, Stuart A. Best, Anne‐Marie Salisbury, Mark Craighead, Ian R. Cooper